F-group (family)
206.1.1.71 Pkinase, Kdo
Ligands and drugs
828
Member domains
520
with ligand contacts (≤ 4 Å)
62.8% of members
476
with DrugDomain annotations
57.5% of members
269
with a DrugBank compound
32.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 206.1.1.71 belongs to X-group 206 Protein kinase/SAICAR synthase/ATP-grasp, which binds 10.2 ligand superclasses per 20 proteins, broader than 96% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB07382 | APJ | N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine | 28 |
| DB16833 | ADP | Adenosine disphosphate | 14 |
| DB12010 | — | Fostamatinib | 10 |
| DB02643 | C15 | N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate | 7 |
| DB03345 | BME | Mercaptoethanol | 6 |
| DB00131 | AMP | Adenosine phosphate | 5 |
| DB00640 | ADN | Adenosine | 4 |
| DB04216 | QUE | Quercetin | 4 |
| DB07524 | C4E | N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine | 4 |
| DB01782 | 537 | Pyrazolanthrone | 3 |
| DB02375 | MYC | Myricetin | 3 |
| DB03777 | BI1 | Bisindolylmaleimide I | 3 |
| DB01268 | B49 | Sunitinib | 2 |
| DB02010 | STU | Staurosporine | 2 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 2 |
| DB04395 | — | Phosphoaminophosphonic Acid-Adenylate Ester | 2 |
| DB04716 | IZA | 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one | 2 |
| DB06933 | 255 | N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide | 2 |
| DB07218 | 73Q | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | 2 |
| DB07268 | 859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 52 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 29 |
| APJ | N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine | 28 |
| CL | CHLORIDE ION | 28 |
| NAmetal | SODIUM ION | 25 |
| 7PE | 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL | 18 |
| 25L | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate | 14 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 14 |
| C15 | N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE | 7 |
| 25A | 5'-O-MONOPHOSPHORYLADENYLYL(2'->5')ADENYLYL(2'->5')ADENOSINE | 6 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 6 |
| BME | BETA-MERCAPTOETHANOL | 6 |
| AMP | ADENOSINE MONOPHOSPHATE | 5 |
| 3RJ | N~2~-(1H-benzimidazol-6-yl)-N~4~-(5-cyclobutyl-1H-pyrazol-3-yl)quinazoline-2,4-diamine | 4 |
| ADN | ADENOSINE | 4 |
| BGE | 4-(4-methyl-1~{H}-imidazol-5-yl)-~{N}-(4-morpholin-4-ylphenyl)pyridin-2-amine | 4 |
| C4E | N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine | 4 |
| HVH | ~{N}-[3-[[5-cyclopropyl-2-[(2-methyl-3,4-dihydro-1~{H}-isoquinolin-6-yl)amino]pyrimidin-4-yl]amino]propyl]cyclobutanecarboxamide | 4 |
| IOD | IODIDE ION | 4 |
| QUE | 3,5,7,3',4'-PENTAHYDROXYFLAVONE | 4 |